Advertisement

Most Recent

image: The Psychiatrist’s Jigsaw

The Psychiatrist’s Jigsaw

By | November 1, 2013

Researchers are piecing together the devilishly complex sets of genetic alterations underlying schizophrenia and bipolar disorder.

4 Comments

image: Going Viral

Going Viral

By | September 1, 2013

From therapeutics to gene transfer, bacteriophages offer a sustainable and powerful method of controlling microbes.

6 Comments

image: Engineering Life

Engineering Life

By , , and | August 1, 2013

Cellular “tinkering” is critical for establishing a new engineering discipline that will lead to the next generation of technologies based on life’s building blocks.

3 Comments

image: Lamarck and the Missing Lnc

Lamarck and the Missing Lnc

By | October 1, 2012

Epigenetic changes accrued over an organism’s lifetime may leave a permanent heritable mark on the genome, through the help of long noncoding RNAs.

21 Comments

image: Best Places to Work Academia, 2012

Best Places to Work Academia, 2012

By | August 1, 2012

On the 10th anniversary of The Scientist’s survey of life science academics, institutions are contending with tighter budgets and larger administrative staffs, while working to sustain and inspire their researchers.

0 Comments

image: Best Places to Work Industry, 2012

Best Places to Work Industry, 2012

By | June 1, 2012

Much has changed in the 10 years since our first survey of industry researchers. Large companies are now looking to small, nimble ones for services as well as innovation.

0 Comments

image: Targeting DNA

Targeting DNA

By | June 1, 2012

After 20 years of high-profile failure, gene therapy is finally well on its way to clinical approval.

13 Comments

image: Freezing Time

Freezing Time

By | May 1, 2012

Targeting the briefest moment in chemistry may lead to an exceptionally strong new class of drugs.

15 Comments

image: What it Takes to Develop Better Drugs for Kids

What it Takes to Develop Better Drugs for Kids

By | March 1, 2012

Over the past 15 years, new laws and regulations in the United States and the European Union have expanded to require the inclusion of pediatric patients in clinical drug trials.  

2 Comments

image: Are the Kids Alright?

Are the Kids Alright?

By | March 1, 2012

Two key pieces of legislation, enacted to spur drugmakers into testing pharmaceutical products in children, are up for reauthorization in the US Congress this October. Have they done their jobs?

6 Comments

Advertisement

Popular Now

  1. The Sum of Our Parts
    Features The Sum of Our Parts

    Putting the microbiome front and center in health care, in preventive strategies, and in health-risk assessments could stem the epidemic of noncommunicable diseases.

  2. Most Earth-like Planet Found
  3. Ancient Viruses as Gene Therapy Vectors
  4. Judge Decides on GM Rice Retraction
Advertisement
Lab Rat Gifts
Lab Rat Gifts
Advertisement
Life Technologies